2018 American Transplant Congress
Treatment of BK Viremia: Single-Center Experience
Nephrology, University of Kentucky, Lexington, KY.
INTRODUCTION:BK viremia (BKV) and BK virus nephropathy (BKVN) is recognized as an emerging problem in renal transplant recipients. Only reduction of immunosuppressants had shown efficacy…2018 American Transplant Congress
Clostridium difficile Recurrence in Abdominal Organ Transplant Recipients: Metronidazole versus Oral Vancomycin
Clostridium difficile infection (CDI) is one of the most common hospital-acquired infections among the general inpatient population with recurrence rates of 20-30% despite appropriate treatment.…2018 American Transplant Congress
Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation
[Background] Long-term administration of calcineurin inhibitors (CNIs) successfully controls rejection of transplanted organs. However, the chronic use of these drugs causes organ damage often resulting…2018 American Transplant Congress
Timeline and Histopathological Characteristics of Graft Failure after Kidney Transplantation: What is Preventable and What is Not?
University of Wisconsin, Madison.
Background: There is limited information on the histopathological characteristics of kidney transplant recipients (KTRs) with graft failure at different post-transplant time intervals. Methods:We addressed this…2018 American Transplant Congress
Characteristics and Outcomes of Kidney Transplant Recipients with More Than 25 Years of a Functioning Graft
University of Wisconsin, Madison.
Background: There is limited information on clinical characteristics and outcomes of kidney transplant recipients (KTRs) with more than 25 years of graft survival.Methods: We addressed…2018 American Transplant Congress
Reducing Discards for Deceased Kidney Donors over Age 50 by Restricting Biopsy Criteria
Clinical Division, Gift of Life Michigan, Ann Arbor, MI.
The placement of kidneys from deceased organ donors of advanced age is an ongoing challenge. An Organ Procurement Organization (OPO) evaluated its discard rate for…2018 American Transplant Congress
Elbasvir-Grazoprevir (Zepatier) is Effective and Safe for the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Virus in the Post Kidney Transplant Patient
Objective: Limited real world data exists regarding the use of direct acting antivirals (DAA) for HCV viremia in renal transplant patients, particularly those with marked…2018 American Transplant Congress
Impact of Cigarette Smoking on Living Kidney Donor
Introduction: Smoking is known to result in the decline of renal allograft function and survival of recipients. However, effect of smoking on living kidney donor…2018 American Transplant Congress
Laparoscopic Donor Nephrectomy Safety: Experience of 500 Cases in Hispanic Population at a Single Institution
Transplantation Surgery, Colombiana de Trasplantes, Bogota, Colombia.
Background: Laparoscopic live donor nephrectomy (LDN) has become the best option in living donation because its safety and low rate of complications. This report aims…2018 American Transplant Congress
Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants
1UCSF, San Francisco; 2Johns Hopkins University, Baltimore.
Transplant (tx) injury from antibody mediated (AMR) and T cell mediated (CMR) rejection, limits indefinite survival after HLA mismatched organ tx. AMR is incompletely diagnosed…
- « Previous Page
- 1
- …
- 299
- 300
- 301
- 302
- 303
- …
- 531
- Next Page »